Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience Corp (TWST)
NASDAQ:TWST
Twist Bioscience (TWST) Stock Price & Analysis
813 Followers
TWST Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.62 - $50.50
Previous Close$47.01
Volume649.41K
Average Volume (3M)940.38K
Market Cap
$2.74B
Enterprise Value$2.52B
Total Cash (Recent Filing)$311.14M
Total Debt (Recent Filing)$91.88M
Price to Earnings (P/E)-14.0
Beta2.46
Next Earnings
Aug 02, 2024EPS Estimate
-$0.77Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.35
Shares Outstanding58,225,999
10 Day Avg. Volume1,248,050
30 Day Avg. Volume940,375
Standard Deviation0.20
R-Squared0.18
Alpha0.00738
Financial Highlights & Ratios
Price to Book (P/B)6.00
Price to Sales (P/S)11.17
Price to Cash Flow (P/CF)-29.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue12.32
Enterprise Value/Gross Profit28.06
Enterprise Value/Ebitda-13.85
Forecast
1Y Price Target
$42.43Price Target Upside-9.74% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Twist Bioscience News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTWST reported stronger than expected revenue and gross margins, raising FY24 revenue guidance due to robust demand in its synthetic biology and next-generation sequencing products.
Market ExpansionWith a focus on expanding its customer base and a serviceable available market of approximately $1.4 billion, TWST showcases significant growth potential in the synthetic biology industry.
Product DemandThe company's Express Genes service is gaining traction with a quick turnaround time of approximately 5-7 days and an average pricing premium of around 58%, indicating strong demand and competitive advantage.
Bears Say
Earnings ForecastBiopharma revenue is expected to be lower than previous guidance, suggesting some challenges in this segment.
Profitability ConcernsDespite strong revenue performance, the path to cash flow profitability remains challenging due to aggressive competition on price.
Sustainability And RatingConcerns about the sustainability of one-time orders due to seasonality and the durability of orders throughout the year lead to an Underweight rating.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TWST FAQ
What was Twist Bioscience Corp’s price range in the past 12 months?
Twist Bioscience Corp lowest stock price was $12.62 and its highest was $50.50 in the past 12 months.
What is Twist Bioscience Corp’s market cap?
Currently, no data Available
When is Twist Bioscience Corp’s upcoming earnings report date?
Twist Bioscience Corp’s upcoming earnings report date is Aug 02, 2024 which is in 76 days.
How were Twist Bioscience Corp’s earnings last quarter?
Twist Bioscience Corp released its earnings results on May 02, 2024. The company reported -$0.79 earnings per share for the quarter, beating the consensus estimate of -$0.816 by $0.026.
Is Twist Bioscience Corp overvalued?
According to Wall Street analysts Twist Bioscience Corp’s price is currently Overvalued.
Does Twist Bioscience Corp pay dividends?
Twist Bioscience Corp does not currently pay dividends.
What is Twist Bioscience Corp’s EPS estimate?
Twist Bioscience Corp’s EPS estimate is -$0.77.
How many shares outstanding does Twist Bioscience Corp have?
Twist Bioscience Corp has 58,225,998 shares outstanding.
What happened to Twist Bioscience Corp’s price movement after its last earnings report?
Twist Bioscience Corp reported an EPS of -$0.79 in its last earnings report, beating expectations of -$0.816. Following the earnings report the stock price went up 28.741%.
Which hedge fund is a major shareholder of Twist Bioscience Corp?
Among the largest hedge funds holding Twist Bioscience Corp’s share is ARK Investment Management LLC. It holds Twist Bioscience Corp’s shares valued at 238M.
---
Twist Bioscience Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$42.43 (-9.74% Downside)
$42.43 (-9.74% Downside)
Blogger Sentiment
Bullish
TWST Sentiment 85%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 18.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.1%
Last 30 Days ▲ 13.0%
Last 30 Days ▲ 13.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
262.17%
12-Months-Change
Fundamentals
Return on Equity
-30.40%
Trailing 12-Months
Asset Growth
-17.69%
Trailing 12-Months
Company Description
Twist Bioscience Corp
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.
---
TWST Company Deck
---
TWST Earnings Call
Q2 2024
0:00 / 0:00
---
TWST Stock 12 Month Forecast
Average Price Target
$42.43
▼(-9.74% Downside)
Technical Analysis
Genetic Technologies
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
Editas Medicine
―
Best Analysts Covering TWST
1 Year
1 Year Success Rate
6/10 ratings generated profit
1 Year Average Return
+1.06%
reiterated a buy rating 16 days ago
Copying Steven Mah's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +1.06% per trade.
---